American Society of Gene Therapy

Preliminary Program

ASGT 7th Annual Meeting
June 2-6, 2004, Minneapolis, Minnesota
Jointly Sponsored by Baylor College of Medicine, Houston, Texas

Program Schedule
(This program is subject to updates/changes.)

Friday, June 4

Scientific Symposium 300
8:00 am – 10:00 am
Hemopoietic: Cancer Stem Cell
Chair
John E. Dick, PhD
Speakers
Peter Dirks, MD, PhD, FRCSC
Dennis Roop, PhD
Craig T. Jordan, PhD

Scientific Symposium 301
8:00 am – 10:00 am
Immunology of Gene Therapy: The Advent of Genetically Modified T Lymphocytes
Chair
Bruce R. Blazar, MD
Speakers
Michel Sadelain, MD, PhD
Michael Jensen, MD
David Klatzmann, MD, PhD
Stanley Riddell, MD

Scientific Symposium 302
8:00 am – 10:00 am
Infectious Diseases: Emerging Infectious Diseases as Opportunities for Gene Therapy
Chair
John J. Rossi, PhD
Speakers
Geoff Symonds, PhD
Claudio Bordignon, MD
Glenn Randall, PhD

Scientific Symposium 303
8:00 am – 10:00 am
Non-Viral: Advances in Non-Viral Gene Transfer
Co-Chairs
Sean M. Sullivan, PhD
Jon Wolff, MD
Speakers
Francis C. Szoka, Jr, PhD
Kam W. Leong, PhD
Michele P. Calos, PhD
Pamela Davis, MD, PhD

Scientific Symposium 304
8:00 am – 10:00 am
Respiratory Tract: Gene and Stem Cell Therapy for Lung Cancer
Co-Chairs
Steven M. Albelda, MD
Raj Batra, MD
Speakers
John J. Nemunaitis, MD
Steven Dubinett, MD
John G. Hay, MD
Daniel H. Sterman, MD

Break
10:00 am – 10:15 am

Scientific Symposium 310
10:15 am – 12:15 pm
Cancer: Genetic Modification of Dendritic Cells
Chair
David T. Curiel, MD, PhD
Speakers
David T. Curiel, MD, PhD
Stephen Gottschalk, MD
Eli Gilboa, PhD
James J. Mule, PhD

Scientific Symposium 311
10:15 am – 12:15 pm
Cardiovascular: Cell and Gene Therapy for Heart Failure
Chair
Todd K. Rosengart, MD
Speaker
Todd K. Rosengart, MD
Barry J. Byrne, MD, PhD
Frank J. Giordano, MD

Scientific Symposium 312
10:15 am – 12:15 pm
Embryonic Stem Cells & Tissue Engineering
Chair
Mervin Yoder, MD
Speaker
George Q. Daley, MD, PhD
Lorenz Studer, MD
Jennifer L. West, PhD

Scientific Symposium 313
10:15 am – 12:15 pm
Genetic Diseases: Non-Gene Replacement Approaches
Chair
Mark A. Kay, MD, PhD
Speakers
Dietor Gruenert, PhD
Ronald G. Crystal, MD
Christopher Walsh, MD, PhD

Scientific Symposium 314
10:15 am – 12:15 pm
Musculo-Skeletal: New Approaches to Therapy of Musculo-Skeletal Diseases
Chair
Michael M. Themis, PhD
Speakers
David W. Russell, MD, PhD
Michael M. Themis, PhD
Josephine Nalbantoglu, PhD
Terence A. Partridge, PhD

Scientific Symposium 315
10:15 am - 12:15 m
Special: Young Investigator’s Symposium
Chair
Malcolm Brenner, MD, PhD
Speakers
Michael A. Barry, PhD
Laurence JN Cooper, MD, PhD
Matthew Weitzman, PhD

Meet-the-Investigator 320
12:30 pm – 1:30 pm
In Vivo Therapy with Stabilized Compacted DNA
Pamela Davis, MD, PhD

Meet-the-Investigator 321
12:30 pm – 1:30 pm
Immune Responses to Gene Therapy: The Final Frontier
Pedro Lowenstein, MD, PhD

Meet-the-Investigator 322
12:30 pm – 1:30 pm
Foamy Virus Vectors
David Russell, MD, PhD

Meet-the-Investigator 323
12:30 pm – 1:30 pm
Do You Really Want to Know What The FDA Thinks When They Say...
Stephanie Simek, PhD

Meet-the-Investigator 324
12:30 pm – 1:30 pm
Cancer Gene Therapy
Savio Woo, PhD

Simultaneous Oral Abstract Sessions
1:45 pm – 4:15 pm

Oral Abstract Session 330
RNA Virus Vectors: New Technologies
Moderators
Michael Bitzer, MD, PhD
Richard Vile, PhD

Oral Abstract Session 331
AAV Vectors: Serotypes and Applications
Moderators
Joseph Rabinowitz, PhD
Arun Srivastava, PhD

Oral Abstract Session 332
Molecular Conjugates
Moderators
David V. Schaffer, PhD
Theresa M. Reineke, PhD

Oral Abstract Session 333
Cardiovascular Gene Therapy
Moderators
J. Kevin Donahue, MD
Douglas Losordo, MD

Oral Abstract Session 334
Gene Therapy for Musculoskeletal Diseases
Moderators
Johnny Huard, PhD
Steven C. Ghivizzani, PhD

Oral Abstract Session 335
Infectious Diseases and Vaccines
Moderators
Philip R. Johnson, MD
Carl H. June, MD

Oral Abstract Session 336
Cancer Immunotherapy
Moderators
Michael Jensen, MD
Catherine M. Bollard, MD

Corporate Symposium
7:00 pm – 10:00 pm
HIV-based Lentiviral Vectors
Supported by VIRxSYS Corporation

Chair
Boro Dropulic, PhD
Speakers
Inder Verma, PhD - Lentiviral Vectors: Old and New Uses

Luigi Naldini, MD, PhD - Stem Cell Gene Transfer by Lentiviral Vectors

Didier Trono, MD - Interactions between HIV, Lentiviral Vectors and Target Cells

John J. Rossi, PhD - Lentiviral Vector Mediated Delivery of Combinatorial RNA-Based Gene Therapy

Carl H. June, MD - Safety and Feasibility of Adoptive Immunotherapy for HIV Infection with Lentiviral Engineered T Cells

Boro Dropulic, PhD - Pre-clinical Development of HIV- Based Lentiviral Vectors for a Phase I Clinical Trial for HIV/AIDS